In this study, we demonstrated that the pregnane alkaloid 1 could downregulate HIF-1α and block the VEGF/VEGFR2 axis and its downstream signaling pathways in triple-negative breast cancer cells. This evidence concerns the gene KDR and triple-negative breast carcinoma.